regulatory
confidence high
sentiment negative
materiality 0.90
Ocean Biomedical, Inc. (OCEA): Nasdaq/NYSE listing notice — Ocean Biomedical receives Nasdaq delisting notice for low-priced stock rule; bid price <=$0.10 for 10 days
Ocean Biomedical, Inc.
- Nasdaq notified Ocean Biomedical on March 14, 2025, that stock closed at $0.10 or less for 10 consecutive trading days.
- This triggers the Low Priced Stocks Rule (Listing Rule 5810(c)(3)(A)(iii)), an additional basis for delisting.
- Company already faced non-compliance with $1 minimum bid price (notified Dec 3, 2024); compliance period ends June 2, 2025.
- Company must submit a letter to Nasdaq Hearings Panel by March 21, 2025, to address the new deficiency.
- Panel will consider this matter in its decision on continued listing on Nasdaq Capital Market.